Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)
Background: Trigeminal neuralgia is one of the most disabling facial pain syndromes. In recent years' new therapeutic strategy, incobotulinumtoxin A has emerged. The aim of the current study was to determine the time and duration of pain in 3 cases with pharmacological treatment and incobotulin...
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Babol University of Medical Sciences
2023-03-01
|
| Ráidu: | Caspian Journal of Internal Medicine |
| Fáttát: | |
| Liŋkkat: | http://caspjim.com/article-1-3161-en.html |